Scarica l'app Stockscreener
4.60
2.13%
-0.10
Dopo l'orario di chiusura:
4.60
Precedente Chiudi:
$4.70
Aprire:
$4.74
Volume 24 ore:
800.48K
Relative Volume:
0.46
Capitalizzazione di mercato:
$442.94M
Reddito:
-
Utile/perdita netta:
$-81.49M
Rapporto P/E:
-5.686
EPS:
-0.809
Flusso di cassa netto:
$-73.48M
1 W Prestazione:
-2.13%
1M Prestazione:
-2.95%
6M Prestazione:
+19.79%
1 anno Prestazione:
-28.90%
Intervallo 1D:
$4.58
$4.885
Intervallo di 1 settimana:
$4.545
$4.885
Portata 52W:
$1.07
$11.46
Rezolute Inc Stock (RZLT) Company Profile
Nome
Rezolute Inc
Settore
Industria
Telefono
650-206-4507
Indirizzo
275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY
Compare RZLT vs VRTX, REGN, ARGX, RVMD, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RZLT
Rezolute Inc
|
4.60 | 452.57M | 0 | -81.49M | -73.48M | -0.809 |
VRTX
Vertex Pharmaceuticals Inc
|
516.44 | 133.25B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
805.97 | 82.16B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
856.94 | 54.80B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
202.00 | 43.99B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
356.01 | 40.62B | 5.76B | 514.49M | 1.10B | 4.4813 |
Rezolute Inc Stock (RZLT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-25 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2025-12-11 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2025-12-11 | Downgrade | Craig Hallum | Buy → Hold |
| 2025-12-11 | Downgrade | Wedbush | Outperform → Neutral |
| 2024-11-05 | Iniziato | Wedbush | Outperform |
| 2024-08-27 | Iniziato | Guggenheim | Buy |
| 2024-07-17 | Iniziato | BTIG Research | Buy |
| 2024-06-04 | Iniziato | Craig Hallum | Buy |
| 2024-04-09 | Iniziato | Maxim Group | Buy |
| 2022-08-02 | Ripresa | Canaccord Genuity | Buy |
| 2022-06-15 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-09-08 | Iniziato | ROTH Capital | Buy |
| 2021-05-27 | Iniziato | Oppenheimer | Outperform |
| 2021-05-25 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Rezolute Inc Borsa (RZLT) Ultime notizie
Bank of America Corp (RZLT) discloses 1.2% Rezolute ownership in 13G/A - Stock Titan
Rezolute, Inc. (RZLT) gains 5.9% reported stake from Dellora Investments - Stock Titan
Rezolute Inc (RZLT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Rezolute Inc (RZLT) Stock News Today - TradingKey
Rezolute (RZLT) Pulls Back 5.4% as Biotech Volatility ResurfacesRSI Oversold Picks - dars.gov.et
Analysts Offer Insights on Healthcare Companies: Rezolute (RZLT) and Boston Scientific (BSX) - The Globe and Mail
H.C. Wainwright Maintains Rezolute(RZLT.US) With Buy Rating, Maintains Target Price $5 - Moomoo
RZLT|Rezolute Inc|Price:4.930|Chg%:-0.060 - TradingKey
RZLT|Rezolute Inc|Price:4.990| - TradingKey
Rezolute Inc (RZLT) Balance Sheet - TradingKey
Rezolute Inc (RZLT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Rezolute Inc (RZLT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Rezolute Inc (RZLT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Rezolute Inc (RZLT) Institutional Confidence - TradingKey
Rezolute Inc (RZLT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Rezolute Inc (RZLT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Rezolute Inc (RZLT) Income Statement - TradingKey
Rezolute Inc (RZLT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Rezolute to Participate in the BTIG Virtual Biotechnology Conference - The Manila Times
Rezolute Management to Meet Investors Online July 28-29 - Stock Titan
Rezolute (RZLT) Q2 2026 Earnings: EPS Beat with 12.33% Surprise Amid No RevenuePeak Earnings Alert - dars.gov.et
Is Rezolute (NASDAQ:RZLT) In A Good Position To Deliver On Growth Plans? - Moomoo
Exploring 3 High Growth Tech Stocks In The US Market - simplywall.st
Rezolute Inc. (RZLT) Edges Higher Amid Positive Momentum, Testing Key ResistanceGamma Exposure - dars.gov.et
Vivani Stock Puts These Obesity And Diabetes Treatment Stocks On The Radar - simplywall.st
Rezolute (RZLT) CMO disposes 3,062 shares in mandated RSU tax sale - Stock Titan
Form 4 Rezolute Inc For: 7 July By Investing.com - Investing.com Nigeria
Rezolute (RZLT) CEO logs automatic RSU tax-withholding share sale in Form 4 - Stock Titan
Rezolute (RZLT) CFO logs RSU tax sell-to-cover, retains 411,400 shares - Stock Titan
RZLTRezolute Inc Options - Finviz
RZLT News | REZOLUTE INC (NASDAQ:RZLT) - ChartMill
Price to earnings forward of Rezolute, Inc. – NASDAQ:RZLT - TradingView
Price to book forward of Rezolute, Inc. – NASDAQ:RZLT - TradingView
Price to earnings forward of Rezolute, Inc. – DUS:6HV1 - TradingView
Enterprise value to revenue forward of Rezolute, Inc. – NASDAQ:RZLT - TradingView
Enterprise value to revenue forward of Rezolute, Inc. – DUS:6HV1 - TradingView
Enterprise value to EBITDA forward of Rezolute, Inc. – DUS:6HV1 - TradingView
Enterprise value to EBIT forward of Rezolute, Inc. – NASDAQ:RZLT - TradingView
Price to sales forward of Rezolute, Inc. – NASDAQ:RZLT - TradingView
Enterprise value to EBIT forward of Rezolute, Inc. – DUS:6HV1 - TradingView
Price to sales forward of Rezolute, Inc. – DUS:6HV1 - TradingView
RZLT Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive SurpriseEarnings Trend Analysis - po-news-eg.net
Rezolute, Inc. Actuals & Estimates (NASDAQ:RZLT) - TradingView
RZLT Forecast — Price Target — Prediction for 2027 - TradingView
A Quick Look at Today's Ratings for Rezolute(RZLT.US), With a Forecast Between $5 to $14 - Moomoo
Rezolute Inc (RZLT) Valuation: PE, PB & Fair Value Analysis - TradingKey
RZLT stock plummets 79% month to date: Here's what you need to know - MSN
RZLT Q1 2026 Earnings: EPS Beats Estimates Amid Ongoing Clinical DevelopmentHigh Growth Earnings - dars.gov.et
Rezolute's Ersodetug Advances in Rare Hypoglycemia Treatment Amid Pharma Growth - Streetwise Reports
Biopharma Developer Unveils Breakthrough Hypoglycemia Treatment Data - Streetwise Reports
Rezolute data: 75% of tumor HI patients came off IV dextrose at ENDO - Stock Titan
Rezolute Inc Azioni (RZLT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.03%
0.33%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):